Sintilimab-induced autoimmune diabetes: A case report and review of the literature

BACKGROUND: With the widespread application of immune checkpoint inhibitor (ICI) therapy, the number of immune-related adverse effects (irAEs) has increased over the years. Autoimmune diabetes mellitus (DM) is a rare irAEs of ICIs and can be troublesome and life threatening. CASE SUMMARY: We report...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jing, Wang, Ying, Tong, Xiang-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855200/
https://www.ncbi.nlm.nih.gov/pubmed/35211559
http://dx.doi.org/10.12998/wjcc.v10.i4.1263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855200/
https://www.ncbi.nlm.nih.gov/pubmed/35211559
http://dx.doi.org/10.12998/wjcc.v10.i4.1263

Ejemplares similares